Low high-density lipoprotein cholesterol as a risk factor in coronary heart disease - A working group report
Low high-density lipoprotein cholesterol as a risk factor in coronary heart disease - A working group report
复制标题
DOI:
10.1161/01.cir.103.17.2213
复制
发表时间:
2001-05-01
期刊:
影响因子:
37.8
通讯作者:
Gotto, AM
中科院分区:
文献类型:
--
作者:
Gotto, AM
LCAT deficiencies markedly reduce HDL-C (to 10 mg/dL [0.3 mmol/L]) and apoA-I concentrations, 11 neither is commonly associated with premature CHD. Several genetic causes of high HDL-C concentrations have been reported, including defects in the genes for CETP and hepatic lipase and polymorphism of lipoprotein lipase. CETP facilitates the transfer of cholesteryl esters among lipoproteins, 9 and genetic CETP deficiency leads to delayed catabolism of both cholesteryl ester and apoA-I, resulting in marked increases in HDL-C and apoA-I concentrations. 12 Despite the expected protective effects of these elevations, evidence suggests that impaired cholesterol transport resulting from genetic CETP deficiency may be associated with an increased risk of premature CHD. 13 Another important component of the RCT process is phospholipid transfer protein (PLTP). PLTP facilitates the transfer of phospholipids between lipoproteins and induces HDL conversion, which remodels the homogeneous HDL fraction into populations of large and small particles similar to pre--HDL particles, the initial acceptors of membrane cholesterol. 14 By producing initial cholesterol acceptors, PLTP increases the capacity of the RCT process. 15 Investigations in PLTP knockout mice16, 17 have indicated that the transfer of phospholipids to HDL may play an essential role in HDL maturation and that when this process is absent, particles are catabolized at an increased rate. Therefore, it seems that 2 steps may be involved in HDL formation. The first involves catalyzation by ABC1 acting on apoA-I to form pre--HDL particles, and the second involves catalyzation by PLTP and LCAT acting on pre-HDL to produce mature HDL.Hepatic lipase, another key enzyme involved in HDL metabolism, is localized mainly to hepatocytes of the hepatic sinusoids, where it hydrolyses TG and the phospholipid of HDL, causing a reduction in HDL particle size. This in turn leads to an increase in HDL catabolism and the lowering of HDL levels. 12, 18